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The penetration of topically applied compounds varies considerably in the different regions of the human body.
The presence of hair follicles significantly contributes to this effect by an increase in surface area and a disruption
of the epidermal barrier towards the lower parts of the hair follicle. The human hair follicle, hereby, serves not only
as a reservoir, but also as a major entry point for topically applied compounds. Topical delivery of active com-
pounds to specific targets within the skin may help reduce side-effects caused by unspecific reactions, and may
help develop new strategies in the prevention and treatment of skin diseases. Various drug carrier and drug
delivery systems are currently being investigated. The aim of these investigational efforts is to direct topically
applied compounds to the different types of hair follicles and, ideally, to specific compartments and cell popu-
lations within the hair follicles. Follicular targeting offers opportunities for new developments, not only in hair
therapy and in the treatment of hair follicle associated diseases but also in gene therapy and immunotherapy.
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The pilosebaceous unit plays an important role in perme-
ation and penetration processes of topically applied com-
pounds. The human hair follicle is not only an important
reservoir but also an entry point for topically applied
substances and significantly contributes to the transport
of drugs into the skin. This is illustrated by the fact that the
penetration of corticosteroids is considerably lower in hair-
less skin, as compared to haired skin (Hueber et al, 1994;
Tenjarla et al, 1999). Similar observations have been made
in tissue engineered skin where the insertion of hair follicles
significantly increased the penetration rate of hydrocorti-
sone (Michel et al, 1999). The follicular penetration of topical
compounds can be monitored in vivo by laser scan
microscopy, a non-invasive technique which produces
serial horizontal sections of the skin (Fig 1). This phenom-
enon may be utilized not only for systemic drug delivery but
also for the localized delivery of active compounds to the
human hair follicle. Drug delivery systems and formulations
designed to selectively target the human hair follicle may
allow the conveyance of relevant doses of active com-
pounds into the follicular duct. Possible applications include
the treatment of hair growth abnormalities, as well as hair
follicle-associated diseases and general skin disorders.
Target Structures in the Human Hair Follicle
The regression of terminal hair follicle (THF) back to vellus
hair-like structures in androgenetic alopecia, but also hair
overgrowth as it occurs in hirsutism, are common clinical
problems. The human hair follicle further plays a central role
in the pathogenesis of hair follicle-associated disorders
such as acne. Beyond this, the modulation of epithelial and
melanocyte stem cells skin may help improve regeneration
and pigmentation. Based on these considerations, we have
defined three major targets in human hair follicles (Fig 2).
The follicular infundibulum: Although the acroinfundibulum
of the hair follicle is covered by an intact, rather impermeable
stratum corneum, this barrier is interrupted in the lower
follicular infundibulum, as the differentiation pattern switches
from epidermal differentiation to a tricholemmal differentia-
tion pattern. Only few to little differentiated corneocytes
remain and the epidermis must be considered as highly
permeable. Due to this increased permeability of the follicular
epithelium, epithelial cells and associated cell populations
such as antigen-presenting cells, mast cells and others are
readily accessible for topically applied compounds.
The sebaceous gland is interconnected with the human
hair follicle via the sebaceous duct, which opens into the
follicular duct in the lower infundibulum. There is evidence
that topically applied compounds entrapped in liposomes
accumulate not only in the hair follicle itself but also in the
sebaceous gland. Bernard et al studied the penetration of
the antiandrogen RU 58841 in normal hairless rat skin and
scarred hairless skin without sebaceous glands. They found
that the solution was localized in the stratum corneum,
whereas liposome-entrapped RU 58841 was mainly local-
ized in the sebaceous glands (Bernard et al, 1997). These
findings suggest that follicular targeting may also be a
promising tool in topical acne therapy.
The bulge region in the outer root sheath, at the insertion
level of the M. arrector pili, is well recognized as the res-
ervoir of epithelial stem cells which are capable of repop-Abbreviations: THF, terminal hair follicle; VHF, vellus hair follicle
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ulating the hair follicle as well as the interfollicular epidermis
(Taylor et al, 2000). Therapeutic manipulation of stem cells
may allow the treatment of hair loss and hair overgrowth, as
well as skin diseases. The recent localization of melanocyte
stem cells to this lower part of the permanent hair follicle
further offers the opportunity to treat pigmentation disorders
(Nishimura et al, 2002). The bulge region is of particular
interest for gene therapeutic approaches. Hair follicles are
easily accessible, and Li et al (1993) demonstrated in vitro
that hair follicles can be targeted by liposomes loaded
with DNA. Building on these findings Domashenko et al
(2000) successfully introduced plasmid DNA encoding for
the lacZ reporter gene into human hair follicles in a xeno-
graft model). The introduction of genes into follicular stem
cells offers wide opportunities for novel treatments of hair
and skin diseases.
Hair Follicle Types
The infundibulum, the sebaceous gland and the bulge re-
gion are important target structures into THF and vellus hair
follicle (VHF). Depending on location and size of the target
structure the application protocols have to be modified ac-
cordingly. For example, targeting of the bulge region in THF
may allow to inactivate stem cells in patients suffering from
hypertrichosis. Activation of stem cells in vellus hair-like
follicles of androgenetic alopecia patients, in contrast, may
help reconvert these hair follicles in strong, pigmented THF.
Precise data on the anatomy and the morphology of the
different types of hair follicles are essential for the devel-
opment of targeting protocols. In a large series of investi-
gations, Viragh and Meuli (1995) found that the bulge region
in human THF of the scalp is located at a depth of 500–800
mm, whereas the entry level of the sebaceous duct is at
Figure 1
Laser scan microscopy allows to visualize the follicular penetra-
tion of topically applied fluorescent compounds such as sodium
fluorescein in vivo. The device provides an investigated field of vision
is 200  200 down to a maximum depth of approximately 250 mm. This
series of scans illustrates the penetration of topically sodium
fluorescein solution (white signal) into a vellus hair infundibulum on
the forearm of a healthy volunteer (a–f). Each image shows a horizontal
section of the same vellus hair follicle infundibulum at different depths
from the skin surface ( hair fiber).
Figure 2
Follicular targeting aims to selectively bring active compounds into human follicles
The infundibulum, the sebaceous gland and the bulge region are important target structures in both, terminal hair follicle and vellus hair follicle.
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approx. 100–500 mm. Only few data are available on VHF.
Although structurally similar to THF there is evidence for a
characteristic histomorphology and histochemistry of VHF.
VHF are smaller than THF and produce fine, silky hair with
an average diameter of 30 mm, which is generally unmedul-
lated and unpigmented. Blume et al (1991) first determined
the density of VHF on different body sites by phototricho-
gramm. In our group, we measured the infundibular volume
of VHF from different body sites by cyanoacrylate stripping.
VHF of the forehead are among the smallest hair follicles of
the human body, whereas the largest VHF are found in the
calf region. Due to the high density of approx. 290 to more
than 400 VHF per cm2 on the forehead as compared ap-
prox. 14 VHF per cm2 on the calf, however, the forehead
holds the highest overall infundibular volume (Otberg et al,
2004). Besides these anatomic characteristics, a wide va-
riety of factors including the drug carrier system, the formu-
lation, temperature, humidity, and pretreatment techniques
of the skin influence the degree of drug deposition in the
pilosebaceous unit. Our research focus is to develop stand-
ardized application protocols, which allow to specifically
target compartments such as the infundibulum or the bulge
region in the different types of hair follicles.
Drug Carrier Systems
It is well recognized that for certain drug delivery systems,
hair follicles are privileged penetration pathways. They enter
faster into these shunts than through the stratum corneum
and hereby offer the possibility to create high local con-
centrations of the active compounds within the follicular
duct. Among the various drug delivery systems, which are
currently under investigation for topical therapy, liposomes,
and microspheres are most widely used. Successful deliv-
ery of liposomal DNA and protein into hair follicles has been
demonstrated in animal models and human skin. Lieb et al
(1992) delivered calcein by topically applied multilamellar
liposomes to pilosebaceous units in the hamster ear in
vitro). Li et al (1993) demonstrated that hair follicles can be
targeted by liposomes loaded with DNA. Balsari et al (1994)
reported that liposome can deliver monoclonal antibodies
into hair follicles of rats for protection against doxorubicin-
induced alopecia. Topically applied melanin entrapped in
phosphatidylcholine liposomes entered into the hair follicle
cells and the hair shafts forming pigmented hair fibers,
whereas compounds in solution did not enter below the
stratum corneum (Li and Hoffman, 1997). Building on these
findings, Domashenko et al (2000) successfully introduced
plasmid DNA encoding for the lacZ reporter gene into hu-
man hair follicles in a xenograft model.
Compared to liposomes, microspheres offer several ad-
vantages. They display good stability and may allow a con-
trolled release of the active compound (Fig 3). Loaded with
fluorescent dye for experimental studies, the microspheres
can be conveniently followed by fluorescence microscopy.
The penetration properties of the microspheres in the skin
depend on the the size of the particles. Rolland et al (1993)
reported that microspheres of 3–10 mm topically applied to
human skin aggregated in the follicular orifices whereas
particles larger than 10 mm remained on the skin surface.
Particles o1 mm spread widely on intact skin and also
penetrate into the upper layers of the stratum corneum of
interfollicular epidermis, but no penetration into viable ep-
idermis was observed. Specific delivery and controlled
release of adapalene into the hair follicles for the 5 mm
microspheres were demonstrated in vitro and in vivo on
hairless rats and on human skin. Similarly, rhodamine-6G-
loaded 5 mm microspheres dispersed into silicone entered
into follicular duct without penetration within the stratum
corneum (Sumian et al, 1999). Methylene blue-loaded 5 mm
microspheres penetrated into the follicular duct and in
sebaceous glands structures of hairless rat skin without
penetration into the stratum corneum (Mordon et al, 2003).
Building on these findings our group recently performed a
large series of investigations, on the penetration profiles of
microparticles from 6.0 mm down to 0.75 mm on freshly ex-
cised human scalp skin. 6.0 mm particles aggregated in the
infundibular region of terminal hair follicles and penetrated
down to approx. 500 mm, which corresponds approximately
to the entry level of the sebaceous duct (Toll et al, 2004).
Smaller particles with a diameter of 1.5 or 0.75 mm pene-
trated deeper with 40% of terminal hair follicles targeted
down to depth of the bulge region at approx. 800 mm. These
data suggest, that microparticles of different sizes allow
to target compartments within human hair follicles, e.g., the
infundibulum or the bulge region.
Conclusion
In summary, the work of multiple groups proves that the
localized delivery of drugs to the human hair follicle is a
feasible approach. Recent data from our own group
suggest that it is moreover possible to predominantly reach
certain compartments within the hair follicles. Hence,
follicular targeting offers remarkable opportunities for new
developments not only in general dermatotherapy but also
in fields such as gene therapy and immunotherapy.
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Figure3
Microparticles enter selectively into the hair follicle and may yield
high local concentrations of the active compound. The controlled
destabilization of the microspheres may allow a controlled release of
the compounds. The penetrations depth depends on the size of the
particles and the size of the target.
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